Verrica Pharmaceuticals Inc (VRCA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VRCA.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
VRCA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VRCA as an investment opportunity.
- Verrica Pharmaceuticals Inc's variance in analysts' estimates is lower than 9.3% of all US stocks.
- The upside potential (average analyst target price relative to current price) of VRCA is greater than 79.93% of all US stocks.
- Verrica Pharmaceuticals Inc's number of analysts covering the stock is higher than 77.73% of stocks in the small market cap category.
- VRCA has a greater average analyst price target than 37.55% of all US stocks.
- VRCA has a less percent of analysts bearish on the stock than just about 100% of all US stocks.
- The percentage of analysts bullish on the stock of VRCA is higher than just about none of of all US stocks.
- The change in bullishness amongst analysts of VRCA is lower than just about 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Verrica Pharmaceuticals Inc are LUMO, ABUS and VBLT.
Is VRCA a Buy, Hold or Sell? See the POWR Ratings now!